Solubility Enhancement of the Poorly Water-Soluble Antiulcer Drug Famotidine by Inclusion Complexation



  • Shabnam Ain
  • V Gupta
  • Babita K
  • Q Ain
  • J Dahiya


Aqueous solubility is a critical factor for optimum drug delivery. In the present study, we investigated the potential of drug-cyclodextrin complexation as an approach for improving the solubility and bioavailability of famotidine, an H2-receptor antagonist and acid reducing drug which has poor solubility and bioavailability. Solubility improvement of drug by β-cyclodextrin was done by simple complexation approach using physical, kneading and co-precipitation methods and compared with physical mixture. Phase solubility profile indicated that the solubility of famotidine was significantly increased in presence of β-cyclodextrin and shows a linear graph with β-cyclodextrin indicating formation of inclusion complexes in a 1:1 molar ratio. β-Cyclodextrin-famotidine mixture have maximum stability constant 1477.6 M-1. The inclusion complex ratio 1:1 of kneading mixture was selected based on drug release profile and compared with physical mixture. Further characterization was done by  using Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) to identify the physicochemical interaction between drug and carrier and its effect on dissolution. Dissolution rate studies for selected inclusion complex was performed in 0.1 N HCl (pH 1.2), phosphate buffer (pH 7.5) and distilled water (pH 6.8) and compared these to pure drug profile which was found to be 2.34 fold increase in distilled water, 1.83 fold in HCl and 2.01 fold in phosphate buffer (pH 7.5). These results suggest that the kneaded complex of famotidine with β-cyclodextrin as hydrophilic complexation agent can substantially enhance the solubility and dissolution rate. Such complex has promising potential to improve the bioavailability of famotidine.



Download data is not yet available.


Metrics Loading ...


Famotidine, β-Cyclodextrin, kneading, inclusion complex




How to Cite

Ain S, Gupta V, K B, Ain Q, Dahiya J. Solubility Enhancement of the Poorly Water-Soluble Antiulcer Drug Famotidine by Inclusion Complexation. Scopus Indexed [Internet]. 2013 May 31 [cited 2024 May 18];6(1):1983-9. Available from:



Research Articles


in S, Philip B and Pathak K (2008). Preformulative assessment of preformed complexes of gemfibrozil with cyclodextrin. PDA J Pharm Sci Tech 62: 300-308.

Brown D (2003).Orally disintegrating tablets-taste over speed. Drug Del tech 3: 58-61.

Chiou WL and Rigelman S (1971). Pharmaceutical application of solid dispersion system. J. Pharm. Sci 60: 1281-1302.

Dobetti L (2003). Fast disintegrating tablets. US Patent 6: 596,311.

Guyot M, Fawaz F and Bildet J (1995). Physicochemical characterization and dissolution of norfloxacin-cyclodextrin inclusion compounds and PEG solid dispersions. Int. J. Pharm 46: 49–55.

Lee JH, Park TG and Choi HK (1999). Development oforal drug delivery system using floating microspheres. J Microencapsul 16: 715-29.

Loftsson T, Guommundsdottir J, Sigurjonsdottir JF, Sigursson HH, Sigfusson SD, Masson M and Stefansson E (2001). Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int. J. Pharm 212: 29-40.

Patel AR and Vavia PR (2008). Preparation and evaluation of taste masked famotidine formulation using drug/β-cyclodextrin/ polymer ternary complexation approach. AAPS Pharm Sci Tech 9: 544-550.

Rajendrakumar K, Pralhad T and Madhusudan S (2004). Comparative study on co-ground products of rofecoxib with beta-cyclodextrin and its sulfobutyl ether-7 derivative in solution and in the solid state. J. Incl. Phenom. Macro. Chem 49: 259-266.

Rajewski A and Stella VJ (1996). Pharmaceutical applications of cyclodextrins, 2. In vivo drug delivery. J. Pharm. Sci 85: 1142–1169.

Sachan NK, Pushkar S, Solanki SS and Bhatere DS (2010). Enhancement of solubility of acyclovir by solid dispersion and inclusion complexation methods. World Applied Sci. J 11(7): 857-864.

Seager H (1998). Drug delivery products and the Zydis fastdissolving dosage form. J.Pharm Pharmacol 50: 375-82.

Shukla V, Masareddy R, Anghore A and Manvi FV(2009). Influence of β-Cyclodextrin complexation on ketoprofen release from matrix formulation. Int J Pharma Sci Drug Res 1: 195-202.

Someshwar K, Rama G, Harikiran L, Krishna K and Srinivas A (2011). Dissolution enhancement of a poorly water soluble drug using water soluble carriers. Journal of Advanced Pharmaceutical Science 1: 42-46.

Umarunnisha AM, Palanichamy S, Rajesh M, Jeganath S and Thangathirupathi A(2009). Formulation and evaluation of matrix tabletsof Famotidine using hydrophilic polymer. Archives of Applied Science Research 2: 212-220.